Association between ERCC1 polymorphisms and nephrotoxicity in non-small cell lung cancer patients undergoing platinum-based chemotherapy

Authors :: Gerarda J.M. Herder
Cornelis Bernardus Hunting
Johannes C. Kelder
Vera Henriëtte Deneer
Corine de Jong
Source :: Journal of Clinical Oncology. 36:e21177-e21177
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: e21177Background: Platinum-based chemotherapy still remains the most frequently applied first-line treatment for (non)small cell lung cancer ((N)SCLC) not driven by an epidermal growth factor recep...

Subjects :: Cancer Research
Chemotherapy
integumentary system
business.industry
medicine.medical_treatment
medicine.disease
respiratory tract diseases
Nephrotoxicity
Oncology
Epidermal growth factor
Cancer research
Medicine
Non small cell
ERCC1
business
Lung cancer

Full Text Access

Tools